News & Insights
Stay Informed With Our Latest Updates
Explore our comprehensive collection of news and in-depth insights spanning practice areas, industries, and regions.
Firm News February 24, 2026
Gibson Dunn Advises CECO Environmental on $2.2 Billion Strategic Combination with Thermon Group
Gibson Dunn is advising CECO Environmental Corp. on its $2.2 billion strategic combination with Thermon Group Holdings, Inc.
Article February 10, 2026
Columbia Law School Blog Reprints Gibson Dunn Client Alert
The Columbia Law School Blue Sky Blog — a blog on corporations and capital markets — has published the client alert “Gibson Dunn Discusses SEC Corporate-Finance Division’s Helpful Updates to Guidance,” authored by partners Mellissa Campbell Duru, Sebastian L. Fain, Gina Hancock, and Julia Lapitskaya and of counsel Rodrigo Surcan.
Firm News February 3, 2026
Gibson Dunn Advised SpaceX on Acquisition of xAI
Gibson Dunn advised SpaceX on its acquisition of xAI.
Firm News January 29, 2026
Gibson Dunn Advises Modine on Reverse Morris Trust, Including Spin-Off and Combination of Modine’s Performance Technologies with Gentherm
Gibson Dunn is advising Modine, a diversified global leader in thermal management technology and solutions, in a Reverse Morris Trust, including the spin-off and combination of Modine’s Performance Technologies business with Gentherm, a global market leader of innovative thermal management and pneumatic comfort technologies.
Client Alert January 26, 2026
Clarifications, Reversals and Expansions: Corp Fin Delivers Helpful Updates to Guidance
The Division of Corporation Finance of the Securities and Exchange Commission issued several new and updated Compliance and Disclosure Interpretations …
Firm News December 8, 2025
Gibson Dunn Advised Lone Star Funds on Agreement to Sell SPX FLOW to ITT for $4.775 Billion
Gibson Dunn advised Lone Star Funds on its agreement to sell SPX FLOW, Inc., a leading provider of highly engineered equipment and process technologies for attractive end markets including industrial, health, and nutrition, to ITT Inc. for $4.775 billion.
Firm News December 5, 2025
Gibson Dunn Advises Natera on Acquisition of Foresight Diagnostics
Gibson Dunn advised Natera, Inc., a global leader in cell-free DNA and precision medicine, on its acquisition of Foresight Diagnostics, a leader in ultrasensitive molecular residual disease detection.
Firm News November 12, 2025
Gibson Dunn Advising Damora Therapeutics on Sale to Galecto and on $285 Million Private Placement by Galecto
Gibson Dunn is advising privately held biotechnology company Damora Therapeutics, Inc. on its sale to Galecto, Inc.